Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets

Bone is one of the most preferential target site for cancer metastases, particularly for prostate, breast, kidney, lung and thyroid primary tumours. Indeed, numerous chemical signals and growth factors produced by the bone microenvironment constitute factors promoting cancer cell invasion and aggres...

Full description

Bibliographic Details
Main Authors: Annie Schmid-Alliana, Heidy Schmid-Antomarchi, Rasha Al-Sahlanee, Patricia Lagadec, Jean-Claude Scimeca, Elise Verron
Format: Article
Language:English
Published: MDPI AG 2018-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/19/1/148
_version_ 1811283174572949504
author Annie Schmid-Alliana
Heidy Schmid-Antomarchi
Rasha Al-Sahlanee
Patricia Lagadec
Jean-Claude Scimeca
Elise Verron
author_facet Annie Schmid-Alliana
Heidy Schmid-Antomarchi
Rasha Al-Sahlanee
Patricia Lagadec
Jean-Claude Scimeca
Elise Verron
author_sort Annie Schmid-Alliana
collection DOAJ
description Bone is one of the most preferential target site for cancer metastases, particularly for prostate, breast, kidney, lung and thyroid primary tumours. Indeed, numerous chemical signals and growth factors produced by the bone microenvironment constitute factors promoting cancer cell invasion and aggression. After reviewing the different theories proposed to provide mechanism for metastatic progression, we report on the gene expression profile of bone-seeking cancer cells. We also discuss the cross-talk between the bone microenvironment and invading cells, which impacts on the tumour actions on surrounding bone tissue. Lastly, we detail therapies for bone metastases. Due to poor prognosis for patients, the strategies mainly aim at reducing the impact of skeletal-related events on patients’ quality of life. However, recent advances have led to a better understanding of molecular mechanisms underlying bone metastases progression, and therefore of novel therapeutic targets.
first_indexed 2024-04-13T02:06:44Z
format Article
id doaj.art-0669f69d7f4946baa208c61fb0f1d5be
institution Directory Open Access Journal
issn 1422-0067
language English
last_indexed 2024-04-13T02:06:44Z
publishDate 2018-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-0669f69d7f4946baa208c61fb0f1d5be2022-12-22T03:07:26ZengMDPI AGInternational Journal of Molecular Sciences1422-00672018-01-0119114810.3390/ijms19010148ijms19010148Understanding the Progression of Bone Metastases to Identify Novel Therapeutic TargetsAnnie Schmid-Alliana0Heidy Schmid-Antomarchi1Rasha Al-Sahlanee2Patricia Lagadec3Jean-Claude Scimeca4Elise Verron5Centre National de la Recherche Scientifique (CNRS), Université Côte d’Azur, Inserm, iBV, 06108 Nice, FranceCentre National de la Recherche Scientifique (CNRS), Université Côte d’Azur, Inserm, iBV, 06108 Nice, FranceCentre National de la Recherche Scientifique (CNRS), Université Côte d’Azur, Inserm, iBV, 06108 Nice, FranceCentre National de la Recherche Scientifique (CNRS), Université Côte d’Azur, Inserm, iBV, 06108 Nice, FranceCentre National de la Recherche Scientifique (CNRS), Université Côte d’Azur, Inserm, iBV, 06108 Nice, FranceRegenerative Medicine and Skeleton. RMeS-Lab, INSERM UMR 1229, University of Nantes, 44000 Nantes, FranceBone is one of the most preferential target site for cancer metastases, particularly for prostate, breast, kidney, lung and thyroid primary tumours. Indeed, numerous chemical signals and growth factors produced by the bone microenvironment constitute factors promoting cancer cell invasion and aggression. After reviewing the different theories proposed to provide mechanism for metastatic progression, we report on the gene expression profile of bone-seeking cancer cells. We also discuss the cross-talk between the bone microenvironment and invading cells, which impacts on the tumour actions on surrounding bone tissue. Lastly, we detail therapies for bone metastases. Due to poor prognosis for patients, the strategies mainly aim at reducing the impact of skeletal-related events on patients’ quality of life. However, recent advances have led to a better understanding of molecular mechanisms underlying bone metastases progression, and therefore of novel therapeutic targets.http://www.mdpi.com/1422-0067/19/1/148bone metastasesbone tropismbone microenvironmentmolecular mechanismstherapeutic strategies
spellingShingle Annie Schmid-Alliana
Heidy Schmid-Antomarchi
Rasha Al-Sahlanee
Patricia Lagadec
Jean-Claude Scimeca
Elise Verron
Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets
International Journal of Molecular Sciences
bone metastases
bone tropism
bone microenvironment
molecular mechanisms
therapeutic strategies
title Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets
title_full Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets
title_fullStr Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets
title_full_unstemmed Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets
title_short Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets
title_sort understanding the progression of bone metastases to identify novel therapeutic targets
topic bone metastases
bone tropism
bone microenvironment
molecular mechanisms
therapeutic strategies
url http://www.mdpi.com/1422-0067/19/1/148
work_keys_str_mv AT annieschmidalliana understandingtheprogressionofbonemetastasestoidentifynoveltherapeutictargets
AT heidyschmidantomarchi understandingtheprogressionofbonemetastasestoidentifynoveltherapeutictargets
AT rashaalsahlanee understandingtheprogressionofbonemetastasestoidentifynoveltherapeutictargets
AT patricialagadec understandingtheprogressionofbonemetastasestoidentifynoveltherapeutictargets
AT jeanclaudescimeca understandingtheprogressionofbonemetastasestoidentifynoveltherapeutictargets
AT eliseverron understandingtheprogressionofbonemetastasestoidentifynoveltherapeutictargets